• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

摩洛哥药用植物作为 SARS-CoV-2 主蛋白酶抑制剂的计算研究。

Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations.

机构信息

Faculty of Science, Molecular Chemistry and Natural Substances Laboratory, Moulay Ismail University of Meknes, Meknes, Morocco.

EST Khenifra, Sultan Moulay Sliman University, Khenifra, Morocco.

出版信息

J Biomol Struct Dyn. 2021 May;39(8):2971-2979. doi: 10.1080/07391102.2020.1758790. Epub 2020 May 6.

DOI:10.1080/07391102.2020.1758790
PMID:32306860
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7212546/
Abstract

The new Corona-virus, recently called the severe acute respiratory syndrome Coronavirus (SARS-CoV-2) appears for the first time in China and more precisely in Wuhan (December 2019). This disease can be fatal. Seniors, and people with other medical conditions (diabetes, heart disease…), may be more vulnerable and become seriously ill. This is why research into drugs to treat this infection remains essential in several research laboratories. Natural herbal remedies have long been the main, if not the only, remedy in the oral tradition for treating illnesses. Modern medicine has known its success thanks to traditional medicine, the effectiveness of which derives from medicinal plants. The objective of this study is to determine if the components of natural origin have an anti-viral effect and which can prevent humans from infection by this coronavirus using the most reliable method is molecular docking, which used to find the interaction between studied molecules and the protein, in our case we based on the inhibitor of Coronavirus (nCoV-2019) main protease. The results of molecular docking showed that among 67 molecules of natural origin, three molecules (Crocin, Digitoxigenin, and β-Eudesmol) are proposed as inhibitors against the coronavirus based on the energy types of interaction between these molecules and studied protein. [Formula: see text] Communicated by Ramaswamy H. SarmaHighlightsDetermine natural compounds that can have an anti-viral effect and which can prevent humans from infection by this coronavirus;Molecular docking to find interaction between the molecules studied and the receptor of COVID-19;The synthesis of these molecules and the evaluation of their activity against SARS-Cov-2 could be interesting.

摘要

新型冠状病毒,最近被称为严重急性呼吸系统综合征冠状病毒(SARS-CoV-2),首次出现在中国,更确切地说是在武汉(2019 年 12 月)。这种疾病可能是致命的。老年人和患有其他疾病(糖尿病、心脏病等)的人可能更容易受到影响,并变得病重。这就是为什么几个研究实验室仍然必须研究治疗这种感染的药物。天然草药疗法长期以来一直是治疗疾病的主要方法,如果不是唯一方法的话。现代医学得益于传统医学取得了成功,其有效性源自药用植物。本研究的目的是确定天然来源的成分是否具有抗病毒作用,以及使用最可靠的方法——分子对接,是否可以防止人类感染这种冠状病毒。在我们的案例中,我们基于冠状病毒(nCoV-2019)主要蛋白酶抑制剂,分子对接用于寻找研究分子与蛋白质之间的相互作用。研究结果表明,在 67 种天然来源的分子中,有三种分子(藏红花酸、洋地黄毒苷和β-桉叶醇)被提议作为冠状病毒抑制剂,这基于这些分子与研究蛋白之间相互作用的能量类型。[公式:见正文]通讯作者:Ramaswamy H. Sarma 亮点确定具有抗病毒作用并能预防人类感染这种冠状病毒的天然化合物;通过分子对接寻找研究分子与 COVID-19 受体之间的相互作用;这些分子的合成及其对 SARS-CoV-2 的活性评价可能会很有趣。

相似文献

1
Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations.摩洛哥药用植物作为 SARS-CoV-2 主蛋白酶抑制剂的计算研究。
J Biomol Struct Dyn. 2021 May;39(8):2971-2979. doi: 10.1080/07391102.2020.1758790. Epub 2020 May 6.
2
In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2.基于计算机的伊朗药用植物植物成分对 SARS-CoV-2 主要蛋白酶和受体结合域抑制作用的评估。
Molecules. 2021 Sep 21;26(18):5724. doi: 10.3390/molecules26185724.
3
An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study.利用分子对接研究鉴定 SARS-CoV-2 主蛋白酶潜在抑制剂的研究。
J Biomol Struct Dyn. 2021 Jun;39(9):3347-3357. doi: 10.1080/07391102.2020.1763201. Epub 2020 May 13.
4
Promising inhibitors of main protease of novel corona virus to prevent the spread of COVID-19 using docking and molecular dynamics simulation.利用对接和分子动力学模拟筛选新型冠状病毒主蛋白酶抑制剂以阻止 COVID-19 的传播。
J Biomol Struct Dyn. 2021 Aug;39(13):4671-4685. doi: 10.1080/07391102.2020.1779131. Epub 2020 Jun 22.
5
Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (M) of SARS-CoV-2 and inhibit its activity.化合物 Withaone 和咖啡酸苯乙酯被预测可与 SARS-CoV-2 的主要蛋白酶(M)相互作用并抑制其活性。
J Biomol Struct Dyn. 2021 Jul;39(11):3842-3854. doi: 10.1080/07391102.2020.1772108. Epub 2020 Jun 1.
6
Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 integrated computational approach.基于整合计算方法鉴定 SARS-CoV-2 的糜蛋白酶样蛋白酶抑制剂。
J Biomol Struct Dyn. 2021 Apr;39(7):2607-2616. doi: 10.1080/07391102.2020.1751298. Epub 2020 Apr 13.
7
Reckoning γ-Glutamyl-S-allylcysteine as a potential main protease (m) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation.运用对接和分子动力学模拟发现γ-谷氨酰-S-烯丙半胱氨酸可能是新型 SARS-CoV-2 病毒的主要蛋白酶(m)抑制剂。
Drug Dev Ind Pharm. 2021 May;47(5):699-710. doi: 10.1080/03639045.2021.1934857. Epub 2021 Jun 7.
8
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.新型 SARS-CoV-2 病毒主要蛋白酶的批准蛋白酶抑制剂的有效性的计算机评估。
Molecules. 2020 May 29;25(11):2529. doi: 10.3390/molecules25112529.
9
Cameroonian medicinal plants as potential candidates of SARS-CoV-2 inhibitors.喀麦隆药用植物作为新型冠状病毒抑制剂的潜在候选者。
J Biomol Struct Dyn. 2022;40(19):8615-8629. doi: 10.1080/07391102.2021.1914170. Epub 2021 Apr 28.
10
Screening of natural compounds from Cyperus rotundus Linn against SARS-CoV-2 main protease (M): An integrated computational approach.从香附中筛选抗 SARS-CoV-2 主蛋白酶(M)的天然化合物:一种综合计算方法。
Comput Biol Med. 2021 Jul;134:104524. doi: 10.1016/j.compbiomed.2021.104524. Epub 2021 May 29.

引用本文的文献

1
Identification, functional analysis, and clinical applications of defective viral genomes.缺陷病毒基因组的鉴定、功能分析及临床应用
Front Microbiol. 2025 Jul 17;16:1642520. doi: 10.3389/fmicb.2025.1642520. eCollection 2025.
2
Unravelling the mechanism of action of Huashibaidu formula volatile metabolome for the treatment of COVID-19 and its mutants from the perspectives of network pharmacology and molecular docking.从网络药理学和分子对接角度解析化湿败毒方挥发性代谢组治疗新型冠状病毒肺炎及其突变株的作用机制
Medicine (Baltimore). 2025 May 30;104(22):e42669. doi: 10.1097/MD.0000000000042669.
3
Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 M.严重急性呼吸综合征冠状病毒2 M蛋白的结构与功能、免疫逃逸机制、抗病毒药物研发方法及临床应用研究进展
Molecules. 2025 Jan 16;30(2):351. doi: 10.3390/molecules30020351.
4
Anti-MRSA and cytotoxic activities of different solvent extracts from grown in Shubak, Jordan.来自约旦舒巴克种植的 的不同溶剂提取物的抗 MRSA 和细胞毒性活性。
Open Vet J. 2024 Apr;14(4):990-1001. doi: 10.5455/OVJ.2024.v14.i4.6. Epub 2024 Apr 30.
5
Natural compounds may contribute in preventing SARS-CoV-2 infection: a narrative review.天然化合物可能有助于预防新型冠状病毒感染:一项叙述性综述。
Food Sci Hum Wellness. 2022 Sep;11(5):1134-1142. doi: 10.1016/j.fshw.2022.04.005. Epub 2022 Jun 2.
6
Natural medicinal plant products as an immune-boosters: A possible role to lessen the impact of Covid-19.天然药用植物产品作为免疫增强剂:减轻新冠疫情影响的潜在作用。
Case Stud Chem Environ Eng. 2021 Dec;4:100105. doi: 10.1016/j.cscee.2021.100105. Epub 2021 May 5.
7
Exploring Type II Diabetes Inhibitors from Genus Daphne Plant-species: An Integrated Computational Study.探索瑞香属植物物种中的II型糖尿病抑制剂:一项综合计算研究。
Comb Chem High Throughput Screen. 2025;28(8):1413-1442. doi: 10.2174/0113862073262227231005074024.
8
Fragment-based Drug Discovery Strategy and its Application to the Design of SARS-CoV-2 Main Protease Inhibitor.基于片段的药物发现策略及其在 SARS-CoV-2 主蛋白酶抑制剂设计中的应用。
Curr Med Chem. 2024;31(38):6204-6226. doi: 10.2174/0109298673294251240229070740.
9
Repurposing of Plant-based Antiviral Molecules for the Treatment of COVID-19.将植物源抗病毒分子重新用于治疗新冠肺炎
Curr Top Med Chem. 2024;24(7):614-633. doi: 10.2174/0115680266276749240206101847.
10
Quantitative Assessment of Energetic Contributions of Residues in a SARS-CoV-2 Viral Enzyme/Nanobody Interface.定量评估 SARS-CoV-2 病毒酶/纳米抗体界面残基的能量贡献。
J Chem Inf Model. 2024 Mar 25;64(6):2068-2076. doi: 10.1021/acs.jcim.3c01933. Epub 2024 Mar 9.